Orthotopic liver transplantation for unresectable hepatoblastoma
Authors:
- John McCallJMJohn McCall
- Jon PritchardJPJon Pritchard
- Anil DhawanADAnil Dhawan
- Alistair BakerABAlistair Baker
- Giorgina-Mieli VerganiGVGiorgina-Mieli Vergani
- Paolo MuiesanPaolo Muiesan
- Mohamed RelaMRMohamed Rela
- Nigel David HeatonNHNigel David Heaton
- 1 September 2002
- journal article
- research article
- Published by Wolters Kluwer Health in Transplantation
- Vol. 74 (5) , 652-655
Abstract
The outcome of treatment for advanced hepatoblastoma has recently improved after the introduction of preoperative or pre- and postoperative cisplatin-containing chemotherapy combined with complete surgical excision. The role of liver transplantation in a population of patients who have received this regimen has not been clearly defined. Orthotopic liver transplantation (OLT) was performed in 13 children, aged 5 months to 11 years (median 27 months), who were assessed with unresectable hepatoblastoma, and whose pretreatment extent-of-disease was based on radiologic findings of group III (n=11) and group IV (n=2). One child with a multifocal tumor showed pulmonary metastases at presentation, but, according to radiologic studies, the deposits resolved with chemotherapy before liver transplantation. One other child showed exophytic extension of the primary tumor infiltrating the porta hepatis and body of the pancreas. All 13 patients received preoperative chemotherapy to reduce the size of the primary tumor(s) and to treat metastatic spread. Twelve children underwent elective OLT; all are alive and show normal graft function at a mean follow-up of 33 months (range 1–108). One child shows evidence of recurrent disease in the form of pulmonary metastases. One child underwent emergency OLT for acute liver failure after (incomplete) extended right hepatectomy and died from respiratory failure, with no evidence of recurrent tumor 3 weeks posttransplant. Liver transplantation is an effective treatment for unresectable unifocal or multifocal hepatoblastoma confined to the liver. A multidisciplinary approach to the management of hepatoblastoma, with thoughtful collaboration between pediatric oncologists, hepatologists, and liver surgeons, is essential.Keywords
This publication has 25 references indexed in Scilit:
- Improved outcome for children with hepatoblastomaBritish Journal of Surgery, 1995
- Hepatoblastoma — a bit of a success story?European Journal of Cancer, 1994
- Chemotherapy Effects on HepatoblastomaAmerican Journal of Surgical Pathology, 1993
- Treatment of pulmonary metastases of initial stage. I. Hepatoblastoma in childhood. Report from the childrens cancer groupCancer, 1993
- Cisplatin, vincristine, and fluorouracil therapy for hepatoblastoma: a Pediatric Oncology Group study.Journal of Clinical Oncology, 1993
- Primary hepatic tumours in children: A 26—year reviewJournal of Surgical Oncology, 1992
- Effective treatment of unresectable or metastatic hepatoblastoma with cisplatin and continuous infusion doxorubicin chemotherapy: a report from the Childrens Cancer Study Group.Journal of Clinical Oncology, 1991
- The surgical management of children with incompletely resected hepatic cancer is facilitated by intensive chemotherapyJournal of Pediatric Surgery, 1991
- Effectiveness and toxicity of cisplatin and doxorubicin (PLADO) in childhood hepatoblastoma and hepatocellular carcinoma: A siop pilot studyMedical and Pediatric Oncology, 1991
- The clinical features and prognosis of hepatoblastoma: Follow-up studies done on pediatric tumors enrolled in the Japanese pediatric tumor registry between 1971 and 1980. Part ISurgery Today, 1990